Select Medical (NYSE:SEM) Releases FY 2025 Earnings Guidance

Select Medical (NYSE:SEM) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.090-1.190 for the period, compared to the consensus estimate of 1.430. The company issued revenue guidance of $5.4 billion-$5.6 billion, compared to the consensus revenue estimate of $5.8 billion.

Wall Street Analyst Weigh In

Several research firms recently commented on SEM. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. UBS Group decreased their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Royal Bank of Canada boosted their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Thursday, February 13th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Select Medical currently has an average rating of “Hold” and an average target price of $39.50.

Select Medical Price Performance

SEM stock traded down $0.15 during trading on Thursday, hitting $19.11. The stock had a trading volume of 975,271 shares, compared to its average volume of 792,814. The company’s 50 day moving average price is $19.14 and its two-hundred day moving average price is $28.14. Select Medical has a 1-year low of $18.02 and a 1-year high of $40.98. The stock has a market cap of $2.47 billion, a price-to-earnings ratio of 8.93, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a net margin of 3.97% and a return on equity of 15.99%. On average, sell-side analysts forecast that Select Medical will post 1.97 EPS for the current fiscal year.

Insider Activity

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at $605,602.20. This represents a 14.12 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.